Business

An Australian computer scientist is not ‘Satoshi Nakamoto’, the pseudonym attributed to the unknown person widely credited with inventing Bitcoin, a High Court judge has ruled. Dr Craig Wright, who claimed he was Satoshi, was sued by the Crypto Open Patent Alliance (Copa), a non-profit group that includes cryptocurrency firms. During the five-week trial, the
0 Comments
Ian has the latest developments at The Daily Telegraph with Sky News’ City editor Mark Kleinman. He also speaks to David Livingstone, chief client officer at the Wall Street banking giant Citi, about the budget. And Zig Serafin, chief executive of Qualtrics talks to Ian about making businesses more productive. :: Listen and subscribe to
0 Comments
Bitcoin has hit $60,000 for the first time since November 2021 – putting the cryptocurrency in touching distance of a new record high. One Bitcoin cost $60,519 early on Wednesday afternoon after days of huge rises. It’s close to the all time high of $60,655 recorded on 31 October 2021 when many people turned to
0 Comments
Bitcoin has returned to the $50,000 level for the first time since December 2021, riding on the coat tails of a wider rally for US stocks. The world’s largest cryptocurrency, which hit one-month highs last Friday, maintained its momentum on Monday by rising almost 5%. Rivals, such as ether, saw similar percentage moves. Analysts credited
0 Comments
On today’s episode, Ian King speaks to the chief executive of Pandora about the jewellery firm’s latest results. He also discusses a merger between housebuilder Barratt Developments and its smaller rival Redrow. And the Queen Elizabeth Prize for Engineering’s been awarded to two pioneers of wind power – Ian chats to the chairman of the
0 Comments
In today’s episode, Ian King speaks with Dan Ives – managing director of the brokerage and advisory firm Wedbush Securities – to discuss Microsoft’s revenues and AI. Ian Johnston, global pharmaceutical correspondent at the Financial Times, discusses sales of popular weight loss drug ‘Wegvoy’, made by Novo Nordisk – as they say their sales almost
0 Comments